The latest gastro-intestinal cancer news
New data for management of hepatocellular carcinoma
The COSMIC-312 trial met its primary endpoint of progression-free survival, but interim overall survival results…
Browsing: GI Cancers
Should renal cell carcinomas be managed differently in Asia?
The Pan-Asian adaptation of the ESMO guidelines introduces some changes to the standard of care…
Protein variant identified that renders chemotherapy ineffective in gastric cancer
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective…
High immunoscores may help some win the battle against cancer
Cancerous tumours are made up of many more components than just malignant cells from the…
Nivolumab for the adjuvant treatment of oesophageal carcinoma
In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care…
Artificial intelligence to detect colorectal cancer
A Tulane University researcher in the USA found that artificial intelligence can accurately detect and…
Improving drug options for colorectal cancer patients
Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim…
New study in primary liver cancer calls for novel strategies targeting a dynamic landscape of heterogeneous tumours
Clinician scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s Genome Institute…
Bowel cancer patients at high risk of clinical levels of depression
A new study has highlighted the prevalence of depression in bowel cancer patients up to…
CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy
Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS)…